Michael P. Tarnok, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 17,500 shares at $1.55 ($27K) on 2012-04-05, disclosed to the SEC on 2012-04-09.
Open-market purchase of $27k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KERX | BUY | 2009-05-27 | $18K | — | Filing → |
| KERX | BUY | 2007-11-20 | $10K | — | Filing → |